ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664181 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664181; 2) Community: the network communities that were significantly associated with the response to NSC 664181; 3) Molecule: the relationships between components within communities and NSC 664181; 4) MDR: the compounds that were significantly associated with the NSC 664181.

NSC Compound Enrichment Correlation
NSC 746351 Null 0.0385613993886001 0.051924579
NSC 751342 12H-Benzo[g]pyrido[2,1-b]quinazoline-4-carboxamide, N-[2(dimethylamino)ethyl]-12-oxo 0.0385613993886001 0.14169581
NSC 7521 [(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide 0.0385613993886001 -0.13179743
NSC 752270 2,7-Bis-[3-(2-chloro-benzylamino)-propyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate 0.0385613993886001 0.043081535
NSC 759878 Irinotecan hydrochloride (USAN) 0.0385613993886001 0.16150468
NSC 760476 5,6,7,8-tetrafluoronaphtho[2,3-c][1,2,5]thiadiazole-4,9-dione 0.0385613993886001 0.27366133
NSC 100290 Doxypyrromycin hydrochloride 0.0414190425892865 0.23476071
NSC 10466 Aizen Magenta 0.0414190425892865 0.1940621
NSC 113951 6-Bromotoyocamycin 0.0414190425892865 0.2389176
NSC 116693 Null 0.0414190425892865 0.21371931
Total:53  Current:36    [First] [Prev] [Next] [Last]